Literature DB >> 20646859

Quality assessment of frameless fractionated stereotactic radiotherapy using cone beam computed tomography.

Lee-Cheng Peng1, Darren Kahler, Sanjiv Samant, Jonathan Li, Robert Amdur, Jatinder R Palta, Chihray Liu.   

Abstract

PURPOSE: A quality assessment of intracranial stereotactic radiotherapy was performed using cone beam computed tomography (CBCT). Setup errors were analyzed for two groups of patients: (1) those who were positioned using a frameless SonArray (FSA) system and immobilized with a bite plate and thermoplastic (TP) mask (the bFSA group); and (2) those who were positioned by room laser and immobilized using a TP mask (the mLAS group). METHODS AND MATERIALS: A quality assurance phantom was used to study the system differences between FSA and CBCT. The quality assessment was performed using an Elekta Synergy imager (XVI) (Elekta Oncology Systems, Norcross, GA) and an On-Board Imager (OBI) (Varian Medical Systems, Palo Alto, CA) for 25 patients. For the first three fractions, and weekly thereafter, the FSA system was used for patient positioning, after which CBCT was performed to obtain setup errors.
RESULTS: (1) Phantom tests: The mean differences in the isocenter displacements for the two systems was 1.2 ± 0.7 mm. No significant variances were seen between the XVI and OBI units (p~0.208). (2)Patient tests: The mean of the displacements between FSA and CBCT were independent of the CBCT system used; mean setup errors for the bFSA group were smaller (1.2 mm) than those of the mLAS group (3.2 mm) (p < 0.005). For the mLAS patients, the 90th percentile and the maximum rotational displacements were 3° and 5°, respectively. A 4-mm drift in setup accuracy occurred over the treatment course for 1 bFSA patient.
CONCLUSIONS: System differences of less than 1 mm between CBCT and FSA were seen. Error regression was observed for the bFSA patients, using CBCT (up to 4 mm) during the treatment course. For the mLAS group, daily CBCT imaging was needed to obtain acceptable setup accuracies. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20646859     DOI: 10.1016/j.ijrobp.2010.02.011

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

1.  Relocatable fixation systems in intracranial stereotactic radiotherapy. Accuracy of serial CT scans and patient acceptance in a randomized design.

Authors:  A Theelen; J Martens; G Bosmans; R Houben; J J Jager; I Rutten; P Lambin; A W Minken; B G Baumert
Journal:  Strahlenther Onkol       Date:  2011-12-24       Impact factor: 3.621

2.  Clinical Assessment of 2D/3D Registration Accuracy in 4 Major Anatomic Sites Using On-Board 2D Kilovoltage Images for 6D Patient Setup.

Authors:  Guang Li; T Jonathan Yang; Hugo Furtado; Wolfgang Birkfellner; Åse Ballangrud; Simon N Powell; James Mechalakos
Journal:  Technol Cancer Res Treat       Date:  2014-09-15

3.  Frameless fractionated stereotactic radiation therapy of intracranial lesions: impact of cone beam CT based setup correction on dose distribution.

Authors:  Petra Maria Haertl; Rainer Loeschel; Natalia Repp; Fabian Pohl; Oliver Koelbl; Barbara Dobler
Journal:  Radiat Oncol       Date:  2013-06-25       Impact factor: 3.481

Review 4.  Re-irradiation of Recurrent Pineal Germ Cell Tumors with Radiosurgery: Report of Two Cases and Review of Literature.

Authors:  Kenneth Wong; Anthony B Opimo; Arthur J Olch; Sean All; Jonathan F Waxer; Desirae Clark; Justine Cheng; Alisha Chlebik; Anat Erdreich-Epstein; Mark D Krieger; Benita Tamrazi; Girish Dhall; Jonathan L Finlay; Eric L Chang
Journal:  Cureus       Date:  2016-04-25

5.  Evaluation of accuracy and reproducibility of a relocatable maxillary fixation system for fractionated intracranial stereotactic radiation therapy.

Authors:  Majella Russo; Rebecca Owen; Anne Bernard; Vaughan Moutrie; Matthew Foote
Journal:  J Med Radiat Sci       Date:  2015-09-22

6.  Importance of CBCT setup verification for optical-guided frameless radiosurgery.

Authors:  Lei Fu; Harold Perera; Xiao Ying; Yan Yu
Journal:  J Appl Clin Med Phys       Date:  2014-05-08       Impact factor: 2.102

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.